As part of our commitment to supporting businesses within the legal cannabis sector, the Cannabis Trades Association (CTA) provides an overview of the key guidelines on import and export licences for controlled drugs as outlined by the UK government.
To legally import or export controlled drugs, companies must have a valid domestic licence and an account with the National Drug Control System (NDS), an online platform that manages and monitors controlled substance transactions. The NDS is essential for submitting applications electronically, ensuring streamlined processing within ten working days.
Import licences are valid for three months, while export licences are valid for two months or in line with the importing country’s permit requirements. These licences must be renewed periodically to ensure compliance with UK regulations. Accurate and timely submissions are critical, as incorrect or incomplete applications still incur fees, highlighting the importance of diligence in this process.
Special cases apply to the Channel Islands, where specific rules include the availability of a 'frequent exporter' license for companies making 24 or more shipments annually. Additional export restrictions apply to certain substances, particularly those that could be used for capital punishment or torture. These substances require extra scrutiny to ensure they are not misused, demonstrating the importance of ethical considerations in the trade of controlled substances.
Online endorsement of shipment amounts is mandatory, allowing for real-time tracking and accountability of controlled substances. This ensures transparency and helps prevent the diversion of controlled drugs for illicit use. Each license costs £24, a fee that applies even for unused or incorrect applications, underscoring the need for accuracy and compliance.
Understanding these regulations and adhering to them is crucial for businesses operating within the legal cannabis industry. Staying informed about the latest guidelines helps ensure that operations remain compliant, ethical, and sustainable.
For more detailed information, please refer to the UK Government's guidance on controlled drugs import and export licences.
